DKB17001

N/A

Report date: 2024/07/23 16:16:09

Base Information

Drug NameDKB17001
Drug Alias NameDKB17001DKB-17001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder, OveractiveProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDongkoo Bio & Pharma
China Registration ClassN/A

Develop Information

Active CompaniesDongkoo Bio & Pharma
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, OveractiveProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A